Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of BMY-27557-14 (a Rebeccamycin Analog) in Patients With Ovarian Cancer

NCT00006262 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00006262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of BMY-27557-14 (a Rebeccamycin Analog) in Patients With Ovarian Cancer
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2000
Completion date
September 30, 2001
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer